| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 840 | 2021 |
| Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium CH van der Wouden, A Cambon‐Thomsen, E Cecchin, KC Cheung, ... Clinical Pharmacology & Therapeutics 101 (3), 341-358, 2017 | 292 | 2017 |
| A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study JJ Swen, CH van der Wouden, LEN Manson, H Abdullah-Koolmees, ... The Lancet 401 (10374), 347-356, 2023 | 211 | 2023 |
| Dissecting the shared genetic architecture of suicide attempt, psychiatric disorders, and known risk factors N Mullins, JE Kang, AI Campos, JRI Coleman, AC Edwards, H Galfalvy, ... Biological psychiatry 91 (3), 313-327, 2022 | 150 | 2022 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 142 | 2023 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin … CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ... Clinical Pharmacology & Therapeutics 114 (1), 51-68, 2023 | 103 | 2023 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 58 | 2024 |
| Ubiquitous pharmacogenomics (U-PGx): the time for implementation is now. An Horizon2020 program to drive pharmacogenomics into clinical practice E Cecchin, R Roncato, H J Guchelaar, G Toffoli, ... Current pharmaceutical biotechnology 18 (3), 204-209, 2017 | 56 | 2017 |
| Quality of life in patients with nonalcoholic fatty liver disease: A systematic review K Assimakopoulos, K Karaivazoglou, EE Tsermpini, G Diamantopoulou, ... Journal of psychosomatic research 112, 73-80, 2018 | 54 | 2018 |
| Alcohol-induced oxidative stress and the role of antioxidants in alcohol use disorder: a systematic review EE Tsermpini, A Plemenitaš Ilješ, V Dolžan Antioxidants 11 (7), 1374, 2022 | 51 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 49 | 2024 |
| Assessment of the pharmacogenomics educational environment in Southeast Europe C Pisanu, EE Tsermpini, E Mavroidi, T Katsila, GP Patrinos, A Squassina Public health genomics 17 (5-6), 272-279, 2014 | 49 | 2014 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 48 | 2024 |
| Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study CH van der Wouden, S Böhringer, E Cecchin, KC Cheung, ... Pharmacogenetics and genomics 30 (6), 131-144, 2020 | 35 | 2020 |
| Integrating next-generation sequencing in the clinical pharmacogenomics workflow E Giannopoulou, T Katsila, C Mitropoulou, EE Tsermpini, GP Patrinos Frontiers in pharmacology 10, 384, 2019 | 35 | 2019 |
| Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients K Mitropoulos, E Merkouri Papadima, G Xiromerisiou, A Balasopoulou, ... Human genomics 11, 1-10, 2017 | 30 | 2017 |
| Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries K Blagec, JJ Swen, R Koopmann, KC Cheung, ... PloS one 17 (6), e0268534, 2022 | 28 | 2022 |
| Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19: a systematic review EE Tsermpini, U Glamočlija, F Ulucan-Karnak, S Redenšek Trampuž, ... Antioxidants 11 (8), 1609, 2022 | 25 | 2022 |
| Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network … C Runcharoen, K Fukunaga, I Sensorn, N Iemwimangsa, S Klumsathian, ... Human genome variation 8 (1), 7, 2021 | 24 | 2021 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 22 | 2024 |
